𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

✍ Scribed by Baba, T; Convery, P A; Matsumura, N; Whitaker, R S; Kondoh, E; Perry, T; Huang, Z; Bentley, R C; Mori, S; Fujii, S

Book ID
109970706
Publisher
Nature Publishing Group
Year
2008
Tongue
English
Weight
575 KB
Volume
28
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of CD133-1 and CD133-2 in ova
Expression of CD133-1 and CD133-2 in ovarian cancer
✍ G. FERRANDINA; G. BONANNO; L. PIERELLI; A. PERILLO; A. PROCOLI; A. MARIOTTI; M. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 243 KB
Epigenetic regulation of cancer stem cel
Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-Ξ²
✍ Hanning You; Wei Ding; C. Bart Rountree πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 463 KB πŸ‘ 1 views

Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. CD133, a transmembrane glycoprotein, is an important cell surface marker for both stem cells and cancer stem cells in various tissues including liver. CD133 expression has been recently linked to poor prognosis

Insight into the complex regulation of C
Insight into the complex regulation of CD133 in glioma
✍ Benito Campos; Christel C. Herold-Mende πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 406 KB

## Abstract The transmembrane protein CD133 and its extracellular epitope AC133 are controversial cancer markers. In glioma, AC133 demarcates a subpopulation of stem‐like tumor cells, so‐called cancer stem cells (CSCs), which seem to drive tumor formation and are highly resistant to conventional ch